Sanjay Misra Selected Research

Embolic Protection Devices

8/2012	Clinical outcomes in patients with renal artery stenosis treated with stent placement with embolic protection compared with those treated with stent alone.
10/2010	Endovascular intervention for renal artery stenosis.
9/2009	Use of kissing embolic protection devices in the treatment of early bifurcation renal artery stenosis: a case report.
5/2009	Embolic protection device use in renal artery stent placement.
11/2008	Embolic protection devices in patients with renal artery stenosis with chronic renal insufficiency: a clinical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjay Misra Research Topics

Disease

34	Pathologic Constriction (Stenosis) 01/2022 - 01/2003
23	Arteriovenous Fistula 12/2021 - 02/2008
22	Chronic Renal Insufficiency 01/2021 - 10/2006
19	Hyperplasia 04/2021 - 01/2003
19	Hypoxia (Hypoxemia) 10/2020 - 02/2008
19	Renal Artery Obstruction (Renal Artery Stenosis) 09/2019 - 02/2003
8	Fistula 12/2021 - 08/2004
8	Peripheral Arterial Disease 01/2021 - 11/2011
6	Fibrosis (Cirrhosis) 02/2021 - 12/2011
6	Thrombosis (Thrombus) 05/2020 - 01/2003
6	Acute Kidney Injury (Acute Renal Failure) 11/2018 - 11/2008
5	Hemorrhage 06/2021 - 02/2008
4	Hypertension (High Blood Pressure) 01/2019 - 11/2008
4	Infections 01/2019 - 04/2012
4	Neointima 01/2019 - 01/2003
3	Hereditary Hemorrhagic Telangiectasia 01/2022 - 01/2018
3	Vascular Remodeling 09/2019 - 01/2014
3	Solitary Kidney 01/2019 - 08/2013
3	Chronic Limb-Threatening Ischemia 01/2019 - 05/2012
3	Ischemia 01/2019 - 11/2011
3	Proteinuria 12/2017 - 11/2008
3	Essential Hypertension 03/2016 - 12/2011
3	Neoplasms (Cancer) 04/2012 - 01/2008
3	Infarction (Infarctions) 01/2010 - 02/2003
2	Esophageal and Gastric Varices (Esophageal Varices) 06/2021 - 11/2012
2	Varicose Veins (Varicose Vein) 06/2021 - 01/2016
2	Inflammation (Inflammations) 12/2020 - 01/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2019 - 02/2003
2	Wounds and Injuries (Trauma) 01/2019 - 02/2004
2	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 12/2018 - 05/2018
2	Epistaxis (Nosebleed) 01/2018 - 01/2016
2	Abdominal Aortic Aneurysm 01/2016 - 01/2013
2	Mesenteric Ischemia 04/2012 - 11/2010
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022
1	Embolism (Embolus) 06/2021
1	Ulcer 06/2021
1	Fever (Fevers) 06/2021
1	Stroke (Strokes) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Necrosis 10/2020

Drug/Important Bio-Agent (IBA)

9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 05/2008
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2008
7	Polytetrafluoroethylene (Teflon)FDA Link 01/2010 - 01/2003
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2013
6	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2015 - 12/2005
6	Tissue Inhibitor of Metalloproteinase-1IBA 01/2015 - 02/2008
5	CytokinesIBA 01/2020 - 10/2008
4	CreatinineIBA 10/2020 - 02/2003
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 03/2014
4	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2014
4	Tissue Inhibitor of Metalloproteinase-2IBA 11/2016 - 04/2008
4	Matrix Metalloproteinases (MMPs)IBA 08/2010 - 02/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2019
3	CollagenIBA 01/2020 - 06/2010
3	Contrast MediaIBA 01/2020 - 04/2013
3	Pharmaceutical PreparationsIBA 09/2019 - 03/2015
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 08/2013
3	deoxyhemoglobinIBA 08/2013 - 04/2008
3	progelatinaseIBA 05/2008 - 02/2008
2	Neuropilin-1IBA 01/2022 - 01/2019
2	CyanoacrylatesIBA 06/2021 - 02/2008
2	Simvastatin (Zocor)FDA LinkGeneric 12/2020 - 08/2013
2	salicylhydroxamic acid (SHAM)IBA 09/2019 - 01/2012
2	Lipocalin-2IBA 01/2019 - 08/2013
2	Furosemide (Lasix)FDA LinkGeneric 01/2019 - 04/2008
2	Iothalamic Acid (Iotalamic Acid)FDA Link 01/2019 - 08/2013
2	GadoliniumIBA 11/2018 - 11/2013
2	CholesterolIBA 06/2014 - 09/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2010 - 05/2008
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2010 - 05/2008
2	Tissue Inhibitor of MetalloproteinasesIBA 06/2010 - 07/2009
2	MetalsIBA 09/2009 - 06/2008
2	Phenobarbital (Luminal)FDA Link 08/2009 - 05/2008
2	alpha-2-HS-GlycoproteinIBA 02/2009 - 10/2008
1	EndoglinIBA 01/2022
1	activin AIBA 01/2022
1	octyl 2-cyanoacrylateIBA 06/2021
1	SarinIBA 06/2021
1	Ethiodized Oil (Ethiodol)FDA Link 06/2021
1	CX3C Chemokine Receptor 1IBA 04/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	Terazosin (Hytrin)FDA LinkGeneric 01/2021
1	CyclodextrinsIBA 12/2020
1	Tumor Biomarkers (Tumor Markers)IBA 10/2020
1	AnticoagulantsIBA 01/2020

Therapy/Procedure

28	Renal Dialysis (Hemodialysis) 12/2021 - 01/2003
26	Stents 01/2020 - 02/2003
17	Therapeutics 01/2022 - 02/2008
6	Nephrectomy 12/2020 - 12/2011
6	Drug-Eluting Stents 09/2019 - 02/2008
5	Embolic Protection Devices 08/2012 - 11/2008
4	Surgical Amputation (Amputations) 01/2021 - 05/2012
3	Catheters 10/2019 - 10/2012
3	Vascular Surgical Procedures 01/2019 - 11/2011
2	Transplantation 05/2016 - 01/2009
2	Blood Transfusion (Blood Transfusions) 01/2016 - 02/2003
2	Endovascular Procedures 01/2016 - 11/2009
2	Laparoscopic Cholecystectomy 01/2008 - 02/2004
1	Thrombectomy 05/2020